Admission Date:  [**2176-7-30**]     Discharge Date:  [**2176-8-4**]  Date of Birth:   [**2114-2-8**]     Sex:  M  Service:  [**Hospital1 212**]  HISTORY OF PRESENT ILLNESS:  The patient is a 62 year-old male with a past medical history of squamous cell lung cancer treated with right total pneumonectomy, chronic obstructive pulmonary disease on 2 to 3 liters of home oxygen with saturations in the low 90s at baseline, congestive heart failure, and diabetes mellitus type 2 who was recently admitted from [**7-15**] to [**2176-7-19**] for presumed bronchitis or bronchiectasis flare here with recurrent cough, shortness of breath and fevers.
During his last admission two weeks ago he was treated for chronic obstructive pulmonary disease flare versus bronchitis with a ten day Prednisone taper and Augmentin for one week.
He underwent bronchoscopy due to concern for possible endobronchial lesion, which was normal.
The plan was to treat him for one week of Augmentin, skip one week followed by Bactrim for one week, skip one week and then on Augmentin for two weeks for pneumonia prophylaxis.
The last dose of Augmentin was [**2176-7-22**] after being on Augmentin for only three days.
He denied any sinus pain, sore throat, chest pain, abdominal pain, diarrhea, dysuria or joint pain.
He received Lasix 100 mg intravenous twice, 1 mg of Bumex and 1 gram of Ceftriaxone as well as 125 mg of Solu-Medrol.
He was also placed on a heparin drip for a subtherapeutic INR and given morphine and Ativan for sedation.
Stage three squamous cell lung cancer diagnosed in [**2175-2-26**], status post right pneumonectomy in [**2175-6-28**] treated with neoadjuvant radiation therapy and carboplatin and Taxol.
History of prostate cancer diagnosed in [**2172-2-26**], status post radical proctectomy with penile prosthesis in [**2172-8-27**].
ALLERGIES:  Doxepin causes delirium and Levaquin causes prolonged QTs.
MEDICATIONS ON ADMISSION:  Bactrim 800 mg/160 one tablet twice a day for one week skip one week and then Augmentin 500 mg three times a day.
Potassium 40 milliequivalents twice a day.
Protonix 40 mg once daily.
Lasix 160 mg b.i.d., Uniphyl 200 mg q.d., Zestril 2.5 mg q.d., Serevent two puffs b.i.d., Flovent 110 micrograms four puffs twice a day.
Duo-neb solution four times a day as needed.
Amiodarone 200 mg q.d., enteric coated aspirin 325 mg a day, Glyburide 5 mg once a day, Colace 100 mg twice a day, Senna prn, Coumadin 5 mg once a day except for 4 mg on Tuesday and Thursday, Neurontin 300 mg b.i.d., Oxycontin 20 mg t.i.d., Paxil 20 mg q.d., Lipitor 10 mg q.d., Ambien 15 mg q.h.s.
and a regular insulin sliding scale.
HOSPITAL COURSE:  Upon admission to the hospital the patient was transferred to the Medical Intensive Care Unit where he was treated for presumed bronchitis versus tracheobronchitis versus atypical pneumonia.
Blood sputum, urine and stool cultures were sent and Ceftriaxone and Azithromycin were started.
His Ceftriaxone was stopped and he was continued on Azithromycin.
The patient was kept on his usual inhaler and nebulizing medications as well as Azithromycin and intravenous Solu-Medrol.
After hospital day number two and the patient was extubated and improving the Solu-Medrol was switched to Prednisone and was rapidly tapered.
The patient was encouraged to ambulate and was given regular respiratory treatment and chest physical therapy.
As the regular insulin sliding scale was increased and the Prednisone was tapered these values returned closer to normal.
Humibid LA 600 mg b.i.d.
Lasix 160 mg b.i.d.
Potassium 40 milliequivalents po b.i.d.
Uniphyll 200 mg q.d.
Protonix 40 mg q.d.
Zestril 2.5 mg q.d.
Flovent 110 micrograms four puffs b.i.d.
Albuterol nebulizer q 6 hours prn.
Amiodarone 200 mg po q.d.
Enteric coated aspirin 325 mg q.d.
Glyburide 5 mg q.a.m.
Regular insulin sliding scale as per previously.
Colace 100 mg po b.i.d.
Senna two tabs po b.i.d.
Coumadin on hold until [**8-5**].
Prednisone taper over eight days.
Augmentin 500 mg t.i.d.
Lipitor 10 mg q.d.
Neurontin 300 mg po b.i.d.
Oxycodone 20 mg q 8 hours prn.
Paxil 20 mg po q.d.
Ambien 10 to 15 mg po q.h.s.
The patient had been using Care Group Respiratory Services at home for pulmonary physical therapy and O2 assistance and so this was arranged on an outpatient basis, with chest physical therapy and incentive spirometry and other pulmonary treatments.
